On this page
Linagliptin
Active ingredient 6 prescription 8 with labelling
Overview
Source: NDC DirectoryIngredient name
LINAGLIPTIN
Base moiety
LINAGLIPTIN
RxNorm CUI
UNII
786Z46389E
Medication products
11
Brand names
6
Dosage forms
5
FAERS reports
91,381 · not a risk measure
- Linagliptin Powder
- linagliptin and metformin hydrochloride Tablet, Film Coated, Extended Release
- linagliptin and metformin hydrochloride Tablet
- Linagliptin Premix Powder
- Linsgliptin Tablet
- Glyxambi empagliflozin and linagliptin · Tablet, Film Coated
- Jentadueto linagliptin and metformin hydrochloride · Tablet, Film Coated
- Jentadueto XR linagliptin and metformin hydrochloride · Tablet, Film Coated, Extended Release
- Linagliptin and metformin hydrochloride Tablet, Film Coated
- Tradjenta linagliptin · Tablet, Film Coated
- Trijardy XR empagliflozin, linagliptin, metformin hydrochloride · Tablet, Extended Release
Entries without a link are products listed by the FDA that carry no approval record, therapeutic equivalence rating or official labelling, so they have no detail page. Their facts are shown inline.
By dosage form
| Dosage form | Products | Examples |
|---|---|---|
| TABLET, Film Coated | 4 | Glyxambi, Jentadueto, Linagliptin and metformin hydrochloride, Tradjenta |
| Powder | 2 | Linagliptin, Linagliptin Premix |
| TABLET, Film COATED, Extended Release | 2 | linagliptin and metformin hydrochloride, Jentadueto XR |
| Tablet | 2 | linagliptin and metformin hydrochloride, Linsgliptin |
| TABLET, Extended Release | 1 | Trijardy XR |
Sources for this page
| Dataset | Agency | Used for |
|---|---|---|
| NDC Directory | FDA | Ingredient name, strengths, products, labelers, packages |
| DailyMed RxNorm mappings | NLM | RxNorm concept identifier (RxCUI) |
| FAERS | FDA | Adverse event report totals |